About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5670 record(s)
Req # A-2019-001971
Adverse Reaction Report (AER). Report number: 000731565.Organization: Health Canada
March 2020
Req # A-2019-0008
Please provide all quarterly portfolio updates for the SD Tech Fund in fiscal years 2019 and 2020. Please provide the records digitally (via email or Canada Post epost if possible). Please provide any and all communications, including but not limited to meeting minutes, transcripts, audio recordings, email, text messages, briefing notes, memos, etc. regarding Sustainable Development Technology Canada's investments in cleantech companies since January 1, 2019.Organization: Sustainable Development Technology Canada
March 2020
Req # A-2013-000029
Correspondence between the sponsor and Health Canada relating to the approval of APO-MOMETASONE (AQUEOUS NASAL SPRAY).Organization: Health Canada
February 2020
Req # A-2016-000178
Reviewer’s notes for Estragyn Vaginal Cream (Estrone Vaginal Cream) marketed by Searchlight Pharma Inc.Organization: Health Canada
February 2020
Req # A-2016-000926
All records describing substantive changes to the organizational structure of the Healthy Environments and Consumer Safety Branch for the period July 27, 2016 to October 25, 2016.Organization: Health Canada
February 2020
Req # A-2016-001269
All notifiable changes relating to Mint Pharmaceutical Inc.’s Mint-Tadalafil products, Drug Identification Number (DINs) 02451662, 02451670, 02451689 and 02451697.Organization: Health Canada
February 2020
Req # A-2016-001518
Records of communications between Health Canada Tobacco Control Directorate staff and foreign governments related to tobacco warning labels during 2016.Organization: Health Canada
February 2020
Req # A-2016-001759
The most current Risk Management Plan (RMP) and RMP review report for REMICADE (infliximab), Drug Identification Number (DIN) 02244016 by Janssen Inc.Organization: Health Canada
February 2020
Req # A-2017-000622
All documents relating to the packaging of marijuana products, including anything related to the plain packaging of marijuana products. Time Frame March 2016 to August 2017.Organization: Health Canada
February 2020
Req # A-2017-001208
Copies of final versions of Question Period Cards prepared for the Minister or any person responding on the Minister's behalf during the month of December 2017.Organization: Health Canada
February 2020